Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is -23.08% vs 79.31% in Mar 2025
Other Long Term Liabilities
YoY Growth in year ended Mar 2026 is 40.00% vs 0.00% in Mar 2025
Fixed Assets
YoY Growth in year ended Mar 2026 is 19.80% vs 66.48% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 65.41% vs 11.98% in Mar 2025
Compare Balance Sheet Results of Shelter Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
16.61
17.15
-0.54
-3.15%
Share Warrants & Outstandings
Total Reserve
56.05
56.17
-0.12
-0.21%
Shareholder's Funds
76.63
73.32
3.31
4.51%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.75
30.61
-29.86
-97.55%
Secured Loans
0.00
19.53
-19.53
-100.00%
Unsecured Loans
0.75
11.08
-10.33
-93.23%
Deferred Tax Assets / Liabilities
-0.00
-0.18
0.18
100.00%
Other Long Term Liabilities
0.07
0.00
0.07
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.60
19.94
-19.34
-96.99%
Current Liabilities
Trade Payables
1.25
55.59
-54.34
-97.75%
Other Current Liabilities
5.48
3.50
1.98
56.57%
Short Term Borrowings
0.27
34.99
-34.72
-99.23%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
7.00
94.08
-87.08
-92.56%
Total Liabilities
84.23
187.34
-103.11
-55.04%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
9.94
55.11
-45.17
-81.96%
Less: Accumulated Depreciation
2.80
17.87
-15.07
-84.33%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
7.14
37.24
-30.10
-80.83%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
9.82
-9.82
-100.00%
Intangible assets under development
0.00
4.00
-4.00
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.68
0.00
0.68
0.00%
Long Term Loans & Advances
21.37
0.00
21.37
0.00%
Other Non Current Assets
0.00
7.33
-7.33
-100.00%
Total Non-Current Assets
29.18
58.38
-29.20
-50.02%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
24.44
42.42
-17.98
-42.39%
Sundry Debtors
11.81
73.35
-61.54
-83.90%
Cash and Bank
1.08
0.26
0.82
315.38%
Other Current Assets
1.33
0.00
1.33
0.00%
Short Term Loans and Advances
16.40
12.93
3.47
26.84%
Total Current Assets
55.05
128.96
-73.91
-57.31%
Net Current Assets (Including Current Investments)
48.05
34.88
13.17
37.76%
Total Current Assets Excluding Current Investments
55.05
128.96
-73.91
-57.31%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
84.23
187.34
-103.11
-55.04%
Contingent Liabilities
3.64
5.90
-2.26
-38.31%
Total Debt
0.59
44.61
-44.02
-98.68%
Book Value per share (adjusted)
43.18
42.76
0.42
0.98%
Annual - Borrowings
Borrowings 0.80 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -23.08% vs 79.31% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.07 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 40.00% vs 0.00% in Mar 2025
Annual - Fixed Assets
Fixed Assets 7.14 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 19.80% vs 66.48% in Mar 2025
Annual - Investments
Investments 0.68 Cr
in Mar 2026Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 55.05 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 65.41% vs 11.98% in Mar 2025